NK cell line modified to express a potent, DR5 specific variant of TRAIL, show enhanced cytotoxicity in ovarian cancer models.

Heliyon · 2024 · PMC11336271 · PMID 39170449

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

We also observed an increasing trend in granzyme A and B secretion with increasing E:T ratio for OVCAR-3 co-cultured with both NK cell therapies ( Fig. 4 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.